Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 3.32 USD -6.74% Market Closed
Market Cap: 207.2m USD
Have any thoughts about
Fulcrum Therapeutics Inc?
Write Note

Fulcrum Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulcrum Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
EPS (Diluted)
$0
CAGR 3-Years
48%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
EPS (Diluted)
$6
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
EPS (Diluted)
-$3
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
EPS (Diluted)
$0
CAGR 3-Years
-40%
CAGR 5-Years
-24%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
EPS (Diluted)
$4
CAGR 3-Years
19%
CAGR 5-Years
6%
CAGR 10-Years
10%
Eli Lilly and Co
NYSE:LLY
EPS (Diluted)
$9
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
14%

See Also

What is Fulcrum Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-0.3 USD

Based on the financial report for Jun 30, 2024, Fulcrum Therapeutics Inc's EPS (Diluted) amounts to -0.3 USD.

What is Fulcrum Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
39%

Over the last year, the EPS (Diluted) growth was 81%. The average annual EPS (Diluted) growth rates for Fulcrum Therapeutics Inc have been 48% over the past three years , 39% over the past five years .

Back to Top